Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of April 2025. The report specifically details a transaction in the company's own shares executed under a share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Date of Purchase | April 03, 2025 |
| Number of Shares Purchased | 835,136 |
| Highest Price Paid per Share | 394.65 pence |
| Lowest Price Paid per Share | 390.80 pence |
| Volume Weighted Average Price | 396.60 pence |
| Registered Share Capital | 9,035,666,414 ordinary shares |
| Treasury Shares Held | 4,080,205 |
| Voting Shares Outstanding | 9,031,586,209 |
Material Changes
Following the settlement of the repurchase, the company's share capital structure was updated. The number of ordinary shares with voting rights is now 9,031,586,209. This figure is material for shareholders determining notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. It includes a standard disclaimer stating the announcement does not constitute an offer or solicitation of an offer for securities. A full breakdown of individual trades is available via the London Stock Exchange link provided in the filing.
Key Facts for Investor Verification
- Verify the total number of voting shares (9,031,586,209) for compliance with disclosure thresholds.
- Confirm the volume-weighted average price paid (396.60 pence) against market prices on April 03, 2025.
- Review the full trade breakdown at the provided RNS link for granular execution details.
- Note that this filing does not contain operational or financial performance data for the period.